These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23547825)

  • 1. Putting it into perspective: multimarker panels for cardiovascular disease risk assessment.
    Taqui S; Daniels LB
    Biomark Med; 2013 Apr; 7(2):317-27. PubMed ID: 23547825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimarker approach for identifying and documenting mitigation of cardiovascular risk.
    Penn MS; Klemes AB
    Future Cardiol; 2013 Jul; 9(4):497-506. PubMed ID: 23834691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction.
    Tang WH
    Prog Cardiovasc Dis; 2012; 55(1):1-2. PubMed ID: 22824104
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying novel biomarkers for cardiovascular disease risk prediction.
    Ge Y; Wang TJ
    J Intern Med; 2012 Nov; 272(5):430-9. PubMed ID: 22950687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing and assessing cardiovascular biomarkers.
    Dadu RT; Nambi V; Ballantyne CM
    Transl Res; 2012 Apr; 159(4):265-76. PubMed ID: 22424430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics: a new era in cardiology?
    Mercuro G; Bassareo PP; Deidda M; Cadeddu C; Barberini L; Atzori L
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):800-5. PubMed ID: 21934525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.
    Shah SH; Newgard CB
    Circ Cardiovasc Genet; 2015 Apr; 8(2):410-9. PubMed ID: 25901039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for cardiovascular disease: challenges and future directions.
    May A; Wang TJ
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biomarkers in cardiovascular disease: research tools or ready for personalized medicine?
    Stratz C; Amann M; Berg DD; Morrow DA; Neumann FJ; Hochholzer W
    Cardiol Rev; 2012; 20(3):111-7. PubMed ID: 22301714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimarker panels in sepsis.
    Casserly B; Read R; Levy MM
    Crit Care Clin; 2011 Apr; 27(2):391-405. PubMed ID: 21440208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics in hypertension and other cardiovascular diseases.
    Delles C; Neisius U; Carty DM
    Ann Med; 2012 Jun; 44 Suppl 1():S55-64. PubMed ID: 22713150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal peptides: new markers in cardiovascular disease?
    Pemberton CJ
    Biomark Med; 2014; 8(8):1013-9. PubMed ID: 25343673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.
    Marcovina SM; Crea F; Davignon J; Kaski JC; Koenig W; Landmesser U; Pieri PL; Schulz-Menger J; Shaw LJ; Sobesky J
    J Intern Med; 2007 Mar; 261(3):214-34. PubMed ID: 17305644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do novel biomarkers add to existing scores of total cardiovascular risk?
    De Backer G; Graham I; Cooney MT
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):14-7. PubMed ID: 22801065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple marker approach to risk stratification in patients with stable coronary artery disease.
    Schnabel RB; Schulz A; Messow CM; Lubos E; Wild PS; Zeller T; Sinning CR; Rupprecht HJ; Bickel C; Peetz D; Cambien F; Kempf T; Wollert KC; Benjamin EJ; Lackner KJ; Münzel TF; Tiret L; Vasan RS; Blankenberg S
    Eur Heart J; 2010 Dec; 31(24):3024-31. PubMed ID: 20852293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide.
    McGeechan K; Macaskill P; Irwig L; Liew G; Wong TY
    Arch Intern Med; 2008 Nov; 168(21):2304-10. PubMed ID: 19029492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus.
    Nandish S; Wyatt J; Bailon O; Smith M; Oliveros R; Chilton R
    Am J Cardiol; 2011 Aug; 108(3 Suppl):42B-51B. PubMed ID: 21802580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.